South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.
The patient satisfaction survey results were based on the responses of the patients who completed the study: 35 patients in the pen group and 40 patients in the vial and syringe group. Demographic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results